Acta Histochemica et Cytochemica

SJR Rank #7,904H-index: 33SJR: 0.725Best quartile: Q2Open Access
Journal website: aims, scope and author guidelines
Publisher

Japan Society of Histochemistry and Cytochemistry

Country

Japan

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • BiochemistryQ2
  • HistologyQ2
  • Pathology and Forensic MedicineQ2
  • PhysiologyQ2
  • Cell BiologyQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Glycosylation and Glycoproteins ResearchMolecular Biology Techniques and ApplicationsNeuroscience and Neuropharmacology ResearchPancreatic function and diabetesMonoclonal and Polyclonal Antibodies ResearchMetabolism and Genetic DisordersCancer, Hypoxia, and MetabolismErythrocyte Function and PathophysiologyAlkaline Phosphatase Research StudiesNeuropeptides and Animal Physiology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs015304560

Documents per Year

2022202505101520

Detailed Information

ISSN

1347-5800, 0044-5991

SJR Best Quartile

Q2

Region

Asiatic Region

Citations per Document (2 years)

1.95

References per Document

34.80

Coverage

1968-2025

Scope

Acta Histochemica et Cytochemica is the official online journal of the Japan Society of Histochemistry and Cytochemistry. It is intended primarily for rapid publication of concise, original articles in the fields of histochemistry and cytochemistry. Manuscripts oriented towards methodological subjects that contain significant technical advances in these fields are also welcome. Manuscripts in English are accepted from investigators in any country, whether or not they are members of the Japan Society of Histochemistry and Cytochemistry. Manuscripts should be original work that has not been previously published and is not being considered for publication elsewhere, with the exception of abstracts. Manuscripts with essentially the same content as a paper that has been published or accepted, or is under consideration for publication, will not be considered. All submitted papers will be peer-reviewed by at least two referees selected by an appropriate Associate Editor. Acceptance is based on scientific significance, originality, and clarity. When required, a revised manuscript should be submitted within 3 months, otherwise it will be considered to be a new submission. The Editor-in-Chief will make all final decisions regarding acceptance.

Metrics from SCImago Journal Rank 2025. View on SCImago